WHO issues global warning on fake GLP-1 RAs

WHO Global Surveillance and Monitoring System observes increasing reports of “falsified semaglutide products in all geographic regions”  The World Health Organization (WHO) has issued a medical product alert related to three batches of Ozempic discovered in Brazil, the UK and the US late last year.   In a statement issued yesterday (Thursday 20 July 2024)